Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]:
SEC Accession No. 0000318306-98-000004
Filing Date
1998-04-01
Accepted
1998-04-01 00:00:00
Documents
6
Period of Report
1997-12-31
SROs
NONE

Document Format Files

Seq Description Document Type Size
1 FORM 10-K 10-K 191934
2 AGREEMENT OF MERGER AND PLAN OF REORGANIZATION EX-10.11 116355
3 SUBSUDUARUES OF THE REGISTRANT EX-21 140
4 INDEPENDENT AUDITOR'S CONSENT EX-23.1 1373
5 INDEPENDENT AUDITORS' CONSENT EX-23.2 629
6 FDS EX-27 1709
  Complete submission text file 0000318306-98-000004.txt   314307
Mailing Address 2600 N STEMMONS FRWY STE 210 DALLAS TX 75207
Business Address 2600 N STEMMONS FRWY STE 210 DALLAS TX 75207 2149055100
ACCESS PHARMACEUTICALS INC (Filer) CIK: 0000318306 (see all company filings)

EIN.: 830221517 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-K | Act: 34 | File No.: 000-09314 | Film No.: 98584474
SIC: 2834 Pharmaceutical Preparations